Delivery Order SPE2DX22D0029-SPE2D826F00DR
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $791,968.14 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $15,484.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 7, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $91,278.31 firm fixed price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The contract will be performed at the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,314.62 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 13, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 20, 2025, with a ceiling value of $4,515.16. This firm fixed-price delivery order, which is not set-aside and competitively awarded, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,946.92 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 4, 2025, with an ultimate completion date of October 6, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,931.36 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 15, 2025, with an ultimate completion date of October 16, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,532.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,356.56 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 14, 2025, with an ultimate completion date of the same date. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,692.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 23, 2025, with an ultimate completion date of October 24, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is AmerisourceBergen's...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D826F00DRDelivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $33,215.58 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical (designated SPE2DX and running through December 2026). The contract enables AmerisourceBergen to supply pharmaceutical products and medical supplies to support federal military and veteran healthcare systems, with performance conducted at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's competitively awarded federal contracts with DLA demonstrate its capability to fulfill diverse medical supply needs ranging from routine pharmaceutical deliveries to specialized medical equipment. This delivery order represents one component of AmerisourceBergen's ongoing support to the Defense Health Agency and other federal healthcare systems as part of the broader Pharmaceutical Prime Vendor program supporting global military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.2k | 10/1/25 |